{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T04:54:36Z","timestamp":1781499276076,"version":"3.54.1"},"reference-count":159,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Innate antiviral immunity serves as the first line of defence against viral infections by detecting viruses and triggering responses to eliminate infected cells. However, viruses often evade such host defence mechanisms by hijacking essential post-translational modifications (PTMs) involved in these pathways, particularly ubiquitination, which plays a central role in immune signalling and targeted degradation. This makes ubiquitin sites and E3 ligases key targets for developing degradative antiviral therapeutics. Both have been studied extensively for degradative drugs such as Proteolysis Targeting Chimeras (PROTACs), but their antiviral potential still requires further investigation. Parallel advancements in artificial intelligence have transformed drug design, enabling precise\n                    <jats:italic>de novo<\/jats:italic>\n                    design and PTM site predictions, yet AI-based, ubiquitin-centred antiviral strategies remain underexplored. In this review, we connect these areas by examining the role of ubiquitination in antiviral immunity and viral evasion, identifying limitations in current AI-driven approaches, and outlining how AI can be leveraged to design targeted antiviral therapies. We further discuss the need for explainable AI to address interpretability challenges and consider the risks of AI use in healthcare. Finally, we highlight the potential of integrating structural and emerging 4D modelling approaches to better understand dynamic viral protein complexes and support next-generation antiviral design.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2026.1869543","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T04:25:52Z","timestamp":1781497552000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Opening the black box: insights into ubiquitin-mediated control of innate antiviral immunity and AI-enhanced therapeutics"],"prefix":"10.3389","volume":"17","author":[{"given":"Manasvi","family":"Jagannath","sequence":"first","affiliation":[{"name":"Department of Biotechnology, School of Bio Sciences and Technology, Vellore Institute of Technology","place":["Vellore, Tamil Nadu, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananya","family":"Sunderesan","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, School of Bio Sciences and Technology, Vellore Institute of Technology","place":["Vellore, Tamil Nadu, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manshi Kumari","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, School of Bio Sciences and Technology, Vellore Institute of Technology","place":["Vellore, Tamil Nadu, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Sudandiradoss","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, School of Bio Sciences and Technology, Vellore Institute of Technology","place":["Vellore, Tamil Nadu, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.071043","article-title":"Virus-triggered ubiquitination of TRAF3\/6 by cIAP1\/2 is essential for induction of interferon-\u03b2 (IFN-\u03b2) and cellular antiviral response","volume":"285","author":"Mao","year":"2010","journal-title":"J Biol Chem"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-021-00691-y","article-title":"Regulation of antiviral innate immune signaling and viral evasion following viral genome sensing","volume":"53","author":"Chathuranga","year":"2021","journal-title":"Exp Mol Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2013.01.033","article-title":"Structure and ubiquitination-dependent activation of TANK-binding kinase 1","volume":"3","author":"Tu","year":"2013","journal-title":"Cell Rep"},{"key":"B4","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41573-023-00692-8","article-title":"Accelerating antiviral drug discovery: lessons from COVID-19","volume":"22","author":"von Delft","year":"2023","journal-title":"Nat Rev Drug Discov"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1021\/ACS.JCIM.2C00026","article-title":"AI-based protein structure prediction in drug discovery: impacts and challenges","volume":"62","author":"Schauperl","year":"2022","journal-title":"J Chem Inf Model"},{"key":"B6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/S41392-025-02539-7","article-title":"Antiviral drug discovery and development: challenges and future directions","volume":"11","author":"Du","year":"2026","journal-title":"Signal Transduct Target Ther"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/J.VIRUSRES.2025.199642","article-title":"Next-generation antiviral peptides: AI-driven design, translational delivery platforms, and future therapeutic directions","volume":"361","author":"Mashhadi Abolghasem Shirazi","year":"2025","journal-title":"Virus Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41551-021-00689-x","article-title":"Accelerated antimicrobial discovery via deep generative models and molecular dynamics simulations","volume":"5","author":"Das","year":"2021","journal-title":"Nat BioMed Eng"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/J.DRUDIS.2025.104563","article-title":"Machine learning in targeted protein degradation drug design: a technical review of PROTACs and molecular glues","volume":"31","author":"Lin","year":"2026","journal-title":"Drug Discov Today"},{"key":"B11","doi-asserted-by":"publisher","first-page":"5214","DOI":"10.1039\/D2CS00193D","article-title":"PROTACs: past, present and future","volume":"51","author":"Li","year":"2022","journal-title":"Chem Soc Rev"},{"key":"B12","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1007\/S42979-021-00815-1","article-title":"Deep learning: a comprehensive overview on techniques, taxonomy, applications and research directions","volume":"2","author":"Sarker","year":"2021","journal-title":"SN Comput Sci"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fbinf.2022.1036963","article-title":"Opportunities and challenges in interpretable deep learning for drug sensitivity prediction of cancer cells","volume":"2","author":"Samal","year":"2022","journal-title":"Front Bioinf"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1073\/PNAS.2307432120","article-title":"Peering inside the black box of AI","volume":"120","author":"Ornes","year":"2023","journal-title":"Proc Natl Acad Sci USA"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/S12178-025-09961-Y","article-title":"A current review of generative AI in medicine: core concepts, applications, and current limitations","volume":"18","author":"Rouzrokh","year":"2025","journal-title":"Curr Rev Musculoskeletal Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/J.ADDR.2025.115762","article-title":"Small data, big challenges: machine- and deep-learning strategies for data-limited drug discovery","volume":"229","author":"Pallikkavaliyaveetil","year":"2026","journal-title":"Adv Drug Delivery Rev"},{"key":"B17","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41746-024-01270-x","article-title":"A scoping review of reporting gaps in FDA-approved AI medical devices","volume":"7","author":"Muralidharan","year":"2024","journal-title":"NPJ Digital Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/MOLBEV\/MSAG014","article-title":"Viral simulation reveals overestimation bias in within-host phylodynamic migration rate estimates under selection","volume":"43","author":"Ochsner","year":"2026","journal-title":"Mol Biol Evol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1093\/abbs\/gmu133","article-title":"Regulation of cellular innate antiviral signaling by ubiquitin modification","volume":"47","author":"Lin","year":"2015","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"B20","doi-asserted-by":"publisher","first-page":"7427","DOI":"10.1007\/s00018-021-04001-7","article-title":"The crosstalk between viral RNA- and DNA-sensing mechanisms","volume":"78","author":"Cai","year":"2021","journal-title":"Cell Mol Life Sci"},{"key":"B21","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/j.1365-2249.2010.04196.x","article-title":"Recent insights into the role of Toll-like receptors in viral infection","volume":"161","author":"Carty","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2024.102460","article-title":"Rethinking Toll-like receptor signalling","volume":"91","author":"Bryant","year":"2024","journal-title":"Curr Opin Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R700009200","article-title":"Toll-like receptors and type I interferons","volume":"282","author":"Uematsu","year":"2007","journal-title":"J Biol Chem"},{"key":"B24","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.cytogfr.2014.06.005","article-title":"Regulation of RIG-I-like receptor signaling by host and viral proteins","volume":"25","author":"Chiang","year":"2014","journal-title":"Cytokine Growth Factor Rev"},{"key":"B25","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/ni0704-699","article-title":"RIGging an antiviral defense\u2014it\u2019s in the CARDs","volume":"5","author":"Levy","year":"2004","journal-title":"Nat Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/s41423-020-00602-7","article-title":"Regulation of RIG-I-like receptor-mediated signaling: interaction between host and viral factors","volume":"18","author":"Onomoto","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2024.02.019","article-title":"New frontiers in the cGAS-STING intracellular DNA-sensing pathway","volume":"57","author":"Dvorkin","year":"2024","journal-title":"Immunity"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1380517","article-title":"cGAS: action in the nucleus","volume":"15","author":"Lu","year":"2024","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/1873-3468.70251","article-title":"STING agonists as antiviral agents","volume":"600","author":"Nelson","year":"2025","journal-title":"FEBS Lett"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa2630","article-title":"Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation","volume":"347","author":"Liu","year":"2015","journal-title":"Sci (1979)"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1172739","article-title":"Interplay between RNA viruses and cGAS\/STING axis in innate immunity","volume":"13","author":"Amurri","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41392-025-02264-1","article-title":"Pattern recognition receptors: function, regulation and therapeutic potential","volume":"10","author":"Chen","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2021.12.005","article-title":"K63 ubiquitination in immune signaling","volume":"43","author":"Madiraju","year":"2022","journal-title":"Trends Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.362608","article-title":"TRIM32 protein modulates type I interferon induction and cellular antiviral response by targeting MITA\/STING protein for K63-linked ubiquitination","volume":"287","author":"Zhang","year":"2012","journal-title":"J Biol Chem"},{"key":"B35","doi-asserted-by":"publisher","first-page":"103915","DOI":"10.1016\/j.cellimm.2019.04.003","article-title":"E3 ubiquitin ligases, the powerful modulator of innate antiviral immunity","volume":"340","author":"Zheng","year":"2019","journal-title":"Cell Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/cr.2010.170","article-title":"Expanding role of ubiquitination in NF-\u03baB signaling","volume":"21","author":"Liu","year":"2010","journal-title":"Cell Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/J.MOLCEL.2016.09.014","article-title":"The K48-K63 branched ubiquitin chain regulates NF-\u03baB signaling","volume":"64","author":"Ohtake","year":"2016","journal-title":"Mol Cell"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01296","article-title":"Recent advances and contradictions in the study of the individual roles of ubiquitin ligases that regulate RIG-I-like receptor-mediated antiviral innate immune responses","volume":"11","author":"Oshiumi","year":"2020","journal-title":"Front Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-00564-w","article-title":"The SUMOylation of TAB2 mediated by TRIM60 inhibits MAPK\/NF-\u03baB activation and the innate immune response","volume":"18","author":"Gu","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1073\/PNAS.2420190122","article-title":"MDA5 ISGylation is crucial for immune signaling to control viral replication and pathogenesis","volume":"122","author":"Sarkar","year":"2025","journal-title":"Proc Natl Acad Sci USA"},{"key":"B41","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/S41421-018-0010-9","article-title":"TRIM29 negatively controls antiviral immune response through targeting STING for degradation","volume":"4","author":"Li","year":"2018","journal-title":"Cell Discov"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.4049\/JIMMUNOL.1701569","article-title":"TRIM29 negatively regulates the type I IFN production in response to RNA virus","volume":"201","author":"Xing","year":"2018","journal-title":"J Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.mucimm.2024.10.004","article-title":"TRIM29 controls enteric RNA virus-induced intestinal inflammation by targeting NLRP6 and NLRP9b signaling pathways","volume":"18","author":"Wang","year":"2025","journal-title":"Mucosal Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/s41467-017-00101-w","article-title":"TRIM29 promotes DNA virus infections by inhibiting innate immune response","volume":"8","author":"Xing","year":"2017","journal-title":"Nat Commun"},{"key":"B45","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1038\/s41467-024-44745-x","article-title":"Loss of TRIM29 mitigates viral myocarditis by attenuating PERK-driven ER stress response in male mice","volume":"15","author":"Wang","year":"2024","journal-title":"Nat Commun"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3580","article-title":"Identification of a role for TRIM29 in the control of innate immunity in the respiratory tract","volume":"17","author":"Xing","year":"2016","journal-title":"Nat Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202002484","article-title":"The functional deubiquitinating enzymes in control of innate antiviral immunity","volume":"8","author":"Zong","year":"2020","journal-title":"Adv Sci"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.839624","article-title":"The role of deubiquitinases in virus replication and host innate immune response","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Microbiol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2017.06.010","article-title":"Structure and function of viral deubiquitinating enzymes","volume":"429","author":"Bailey-Elkin","year":"2017","journal-title":"J Mol Biol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.add0082","article-title":"The SARS-CoV-2 papain-like protease suppresses type I interferon responses by deubiquitinating STING","volume":"16","author":"Cao","year":"2023","journal-title":"Sci Signal"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1015287108","article-title":"Molecular basis for ubiquitin and ISG15 cross-reactivity in viral ovarian tumor domains","volume":"108","author":"Akutsu","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2016.06.004","article-title":"Pathogen mimicry of host protein-protein interfaces modulates immunity","volume":"58","author":"Guven-Maiorov","year":"2016","journal-title":"Semin Cell Dev Biol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"4665","DOI":"10.1007\/s11033-023-08389-2","article-title":"Molecular mimicry of host short linear motif-mediated interactions utilised by viruses for entry","volume":"50","author":"Goswami","year":"2023","journal-title":"Mol Biol Rep"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003183","article-title":"Poxvirus targeting of E3 ligase \u03b2-TrCP by molecular mimicry: a mechanism to inhibit NF-\u03baB activation and promote immune evasion and virulence","volume":"9","author":"Mansur","year":"2013","journal-title":"PloS Pathog"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1101\/gad.926401","article-title":"Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism involving a Cullin-containing complex","volume":"15","author":"Querido","year":"2001","journal-title":"Genes Dev"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2237183100","article-title":"Epstein\u2013Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK\/IKK\u03b1-dependent noncanonical NF-\u03baB activation","volume":"101","author":"Luftig","year":"2004","journal-title":"Proc Natl Acad Sci"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1111\/sji.70016","article-title":"The role of Epstein\u2013Barr virus molecular mimicry in various autoimmune diseases","volume":"101","author":"Munir","year":"2025","journal-title":"Scand J Immunol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"9403","DOI":"10.1038\/s41467-024-53658-8","article-title":"Molecular mimicry as a mechanism of viral immune evasion and autoimmunity","volume":"15","author":"Maguire","year":"2024","journal-title":"Nat Commun"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1093\/DATABASE\/BAAB012","article-title":"Post-translational modifications in proteins: resources, tools and prediction methods","volume":"2021","author":"Ramazi","year":"2021","journal-title":"Database"},{"key":"B60","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/S13321-025-01019-Y","article-title":"Leveraging AI to explore structural contexts of post-translational modifications in drug binding","volume":"17","author":"Medvedev","year":"2025","journal-title":"J Cheminf"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-019-2677-9","article-title":"DeepUbi: a deep learning framework for prediction of ubiquitination sites in proteins","volume":"20","author":"Fu","year":"2019","journal-title":"BMC Bioinf"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5125103","article-title":"Prediction of ubiquitination sites using UbiNets","volume":"2018","author":"Yadav","year":"2018","journal-title":"Adv Fuzzy Syst"},{"key":"B63","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12918-018-0628-0","article-title":"Large-scale prediction of protein ubiquitination sites using a multimodal deep architecture","volume":"12","author":"He","year":"2018","journal-title":"BMC Syst Biol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btw701","article-title":"ESA-UbiSite: accurate prediction of human ubiquitination sites by identifying a set of effective negatives","volume":"33","author":"Wang","year":"2017","journal-title":"Bioinformatics"},{"key":"B65","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbaf616","article-title":"A comprehensive benchmarking of the AlphaFold3 for predicting biomacromolecules and their interactions","volume":"26","author":"Peng","year":"2025","journal-title":"Brief Bioinform"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/J.XCRP.2025.102796","article-title":"AlphaFold modeling of polyubiquitin complexes and covalently linked proteins","volume":"6","author":"F\u00e1bi\u00e1n","year":"2025","journal-title":"Cell Rep Phys Sci"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-024-01791-x","article-title":"Protein interactions in human pathogens revealed through deep learning","volume":"9","author":"Humphreys","year":"2024","journal-title":"Nat Microbiol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/bs.enz.2025.06.005","article-title":"Computational approaches for designing viral protease inhibitors","volume":"58","author":"Bonardi","year":"2025","journal-title":"Enzymes (Essen)"},{"key":"B70","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1021\/ci400418c","article-title":"De novo design of drug-like molecules by a fragment-based molecular evolutionary approach","volume":"54","author":"Kawai","year":"2014","journal-title":"J Chem Inf Model"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1093\/PROTEIN\/GZAE011","article-title":"Computational methods for protein design","volume":"37","author":"Ferruz","year":"2024","journal-title":"Protein Eng Des Sel"},{"key":"B72","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s43586-025-00383-1","article-title":"Computational protein design","volume":"5","author":"Albanese","year":"2025","journal-title":"Nat Rev Methods Primers"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1039\/D1SC04444C","article-title":"Structure-based de novo drug design using 3D deep generative models","volume":"12","author":"Li","year":"2021","journal-title":"Chem Sci"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s11030-021-10217-3","article-title":"Artificial intelligence to deep learning: machine intelligence approach for drug discovery","volume":"25","author":"Gupta","year":"2021","journal-title":"Mol Divers"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1007\/s10462-021-10058-4","article-title":"Machine learning in drug discovery: a review","volume":"55","author":"Dara","year":"2022","journal-title":"Artif Intell Rev"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aap7885","article-title":"Deep reinforcement learning for de novo drug design","volume":"4","author":"Popova","year":"2018","journal-title":"Sci Adv"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.5c00861","article-title":"Machine learning for de novo molecular generation: a comprehensive review","volume":"17","author":"Chen","year":"2026","journal-title":"ACS Chem Neurosci"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.sbi.2021.10.001","article-title":"Deep learning approaches for de novo drug design: an overview","volume":"72","author":"Wang","year":"2022","journal-title":"Curr Opin Struct Biol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1007\/s11030-024-11047-9","article-title":"Generative adversarial network (GAN) model-based design of potent SARS-CoV-2 Mpro inhibitors using the electron density of ligands and 3D binding pockets: insights from molecular docking, dynamics simulation, and MM-GBSA analysis","volume":"29","author":"Chakraborty","year":"2025","journal-title":"Mol Divers"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2021.104967","article-title":"De novo design of novel protease inhibitor candidates in the treatment of SARS-CoV-2 using deep learning, docking, and molecular dynamic simulations","volume":"139","author":"Arshia","year":"2021","journal-title":"Comput Biol Med"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.7b00414","article-title":"Recurrent neural network model for constructive peptide design","volume":"58","author":"M\u00fcller","year":"2018","journal-title":"J Chem Inf Model"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1007\/s10822-025-00639-8","article-title":"Ai-driven de novo design of customizable membrane permeable cyclic peptides","volume":"39","author":"Yunxiang","year":"2025","journal-title":"J Comput-Aided Mol Des"},{"key":"B83","doi-asserted-by":"publisher","first-page":"26592","DOI":"10.1021\/acs.jmedchem.5c02889","article-title":"Correction to \u201cAI-driven de novo design and development of nontoxic DYRK1A inhibitors","volume":"68","author":"Garc\u00eda","year":"2025","journal-title":"J Med Chem"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1021\/ACS.JCIM.4C00247","article-title":"Recent advances in automated structure-based de novo drug design","volume":"64","author":"Tang","year":"2024","journal-title":"J Chem Inf Model"},{"key":"B85","doi-asserted-by":"publisher","first-page":"6897","DOI":"10.1021\/acs.jmedchem.4c02975","article-title":"Deubiquitinase-targeting chimeras (DUBTACs) as a potential paradigm-shifting drug discovery approach","volume":"68","author":"Ma","year":"2025","journal-title":"J Med Chem"},{"key":"B86","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/S43556-022-00112-0","article-title":"An overview of PROTACs: a promising drug discovery paradigm","volume":"3","author":"Liu","year":"2022","journal-title":"Mol BioMed"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3389\/FCELL.2026.1812881","article-title":"Editorial: The ubiquitin-proteasome system and cellular signaling: mechanisms and regulatory roles in cancer and infectious diseases","volume":"14","author":"Islam","year":"2026","journal-title":"Front Cell Dev Biol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/s41392-024-02004-x","article-title":"Targeted protein degradation: advances in drug discovery and clinical practice","volume":"9","author":"Zhong","year":"2024","journal-title":"Signal Transduction Targeted Ther"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1080\/17576180.2025.2481021","article-title":"Conquering PROTAC molecular design and drugability","volume":"17","author":"Bhole","year":"2025","journal-title":"Bioanalysis"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1002\/wcms.70013","article-title":"Rational proteolysis targeting chimera design driven by molecular modeling and machine learning","volume":"15","author":"Tan","year":"2025","journal-title":"Wiley Interdiscip Rev Comput Mol Sci"},{"key":"B91","doi-asserted-by":"publisher","first-page":"7133","DOI":"10.1038\/s41467-022-34807-3","article-title":"DeepPROTACs is a deep learning-based targeted degradation predictor for PROTACs","volume":"13","author":"Li","year":"2022","journal-title":"Nat Commun"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1093\/BIOINFORMATICS\/BTAF191","article-title":"Accurate PROTAC-targeted degradation prediction with DegradeMaster","volume":"41","author":"Liu","year":"2025","journal-title":"Bioinformatics"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1010974","article-title":"Elucidation of genome-wide understudied proteins targeted by PROTAC-induced degradation using interpretable machine learning","volume":"19","author":"Xie","year":"2023","journal-title":"PloS Comput Biol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1039\/d5cc03325j","article-title":"Click chemistry enables rapid development of potent sEH PROTACs using a direct-to-biology approach","volume":"61","author":"Sch\u00f6nfeld","year":"2025","journal-title":"Chem Commun"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1039\/d3md00719g","article-title":"Deconvoluting low yield from weak potency in direct-to-biology workflows with machine learning","volume":"15","author":"McCorkindale","year":"2024","journal-title":"RSC Med Chem"},{"key":"B96","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1080\/17568919.2025.2453418","article-title":"PROTACs in the treatment of viral diseases","volume":"17","author":"Bhole","year":"2025","journal-title":"Future Med Chem"},{"key":"B97","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1021\/acs.biochem.2c00245","article-title":"Molecular glues: the adhesive connecting targeted protein degradation to the clinic","volume":"62","author":"Sasso","year":"2022","journal-title":"Biochemistry"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1017\/erm.2012.10","article-title":"Features of protein-protein interactions that translate into potent inhibitors: topology, surface area and affinity","volume":"14","author":"Smith","year":"2012","journal-title":"Expert Rev Mol Med"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbac165","article-title":"Structural landscapes of PPI interfaces","volume":"23","author":"Rodrigues","year":"2022","journal-title":"Brief Bioinform"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.scib.2024.03.056","article-title":"Targeting the undruggables\u2014the power of protein degraders","volume":"69","author":"Zhang","year":"2024","journal-title":"Sci Bull (Beijing)"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2024.12.006","article-title":"Routes to molecular glue degrader discovery","volume":"50","author":"Liu","year":"2025","journal-title":"Trends Biochem Sci"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.110712","article-title":"Molecular glue-mediated targeted protein degradation: a novel strategy in small-molecule drug development","volume":"27","author":"Tan","year":"2024","journal-title":"Iscience"},{"key":"B103","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41589-023-01409-z","article-title":"Design principles for cyclin K molecular glue degraders","volume":"20","author":"Kozicka","year":"2023","journal-title":"Nat Chem Biol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13321-024-00930-0","article-title":"Interface-aware molecular generative framework for protein\u2013protein interaction modulators","volume":"16","author":"Wang","year":"2024","journal-title":"J Cheminform"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/J.ANTIVIRAL.2022.105480","article-title":"Targeted protein degradation as an antiviral approach","volume":"210","author":"Chakravarty","year":"2022","journal-title":"Antiviral Res"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1021\/ACSCENTSCI.1C01603","article-title":"Profiling the landscape of drug resistance mutations in neosubstrates to molecular glue degraders","volume":"8","author":"Gosavi","year":"2022","journal-title":"ACS Cent Sci"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/J.APSB.2026.02.020","article-title":"Molecular glue degraders: rational design, specificity engineering, and advanced delivery","author":"Ma","year":"2026","journal-title":"Acta Pharm Sin B"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.7717\/peerj-cs.1629","article-title":"Understanding the black-box: towards interpretable and reliable deep learning models","volume":"9","author":"Qamar","year":"2023","journal-title":"PeerJ Comput Sci"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/J.INFFUS.2023.101805","article-title":"Explainable artificial intelligence (XAI): what we know and what is left to attain trustworthy artificial intelligence","volume":"99","author":"Ali","year":"2023","journal-title":"Inf Fusion"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/J.COMPBIOLCHEM.2025.108599","article-title":"Advancing explainable AI in healthcare: necessity, progress, and future directions","volume":"119","author":"Mohapatra","year":"2025","journal-title":"Comput Biol Chem"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2025.112013","article-title":"In humble defense of unexplainable black box prediction models in healthcare","volume":"189","author":"van Royen","year":"2026","journal-title":"J Clin Epidemiol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PCBI.1013038","article-title":"InteracTor: feature engineering and explainable AI for profiling protein structure-interaction-function relationships","volume":"21","author":"Silva","year":"2025","journal-title":"PloS Comput Biol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1093\/BIOINFORMATICS\/BTAE031","article-title":"Insights into the inner workings of transformer models for protein function prediction","volume":"40","author":"Wenzel","year":"2024","journal-title":"Bioinformatics"},{"key":"B114","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1186\/S12915-025-02456-9","article-title":"An interpretable geometric graph neural network for enhancing the generalizability of drug\u2013target interaction prediction","volume":"23","author":"Xiong","year":"2025","journal-title":"BMC Biol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1002\/ADVS.202508138","article-title":"Interpretable PROTAC degradation prediction with structure\u2010informed deep ternary attention framework","volume":"12","author":"Chen","year":"2025","journal-title":"Adv Sci"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/J.COMPELECENG.2024.109370","article-title":"A review of explainable artificial intelligence in healthcare","volume":"118","author":"Sadeghi","year":"2024","journal-title":"Comput Electr Eng"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1016\/J.BIOORG.2025.108437","article-title":"Recent advances in PROTAC-based antiviral and antibacterial therapeutics","volume":"160","author":"Zhou","year":"2025","journal-title":"Bioorg Chem"},{"key":"B118","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/S41573-021-00371-6","article-title":"PROTAC targeted protein degraders: the past is prologue","volume":"21","author":"B\u00e9k\u00e9s","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1016\/J.DRUDIS.2026.104648","article-title":"Can artificial intelligence transform antiviral drug discovery","volume":"31","author":"Tirosyan","year":"2026","journal-title":"Drug Discov Today"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.3389\/FRAI.2025.1622292","article-title":"Survey and analysis of hallucinations in large language models: attribution to prompting strategies or model behavior","volume":"8","author":"Anh-Hoang","year":"2025","journal-title":"Front Artif Intell"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1109\/ACCESS.2025.3643370","article-title":"Reducing hallucinations in medical AI: a knowledge graph-augmented retrieval system for evidence-based age-related macular degeneration information","volume":"13","author":"Lecu","year":"2025","journal-title":"IEEE Access"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1111\/JEBM.70075","article-title":"Strategies for the analysis and elimination of hallucinations in artificial intelligence generated medical knowledge","volume":"18","author":"Chen","year":"2025","journal-title":"J Evid Based Med"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1073\/PNAS.2415674122","article-title":"Integrative spatiotemporal modeling of biomolecular processes: application to the assembly of the nuclear pore complex","volume":"122","author":"Latham","year":"2025","journal-title":"Proc Natl Acad Sci USA"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1093\/BIB\/BBAF340","article-title":"Beyond static structures: protein dynamic conformations modeling in the post-AlphaFold era","volume":"26","author":"Cui","year":"2025","journal-title":"Brief Bioinform"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1093\/BIB\/BBAG081","article-title":"Structure-informed machine learning for drug discovery: a task-centric perspective","volume":"27","author":"Li","year":"2026","journal-title":"Brief Bioinform"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1016\/J.SBI.2025.103001","article-title":"Dynamics-based drug discovery by time-resolved cryo-EM","volume":"91","author":"Mao","year":"2025","journal-title":"Curr Opin Struct Biol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04671-8","article-title":"USP14-regulated allostery of the human proteasome by time-resolved cryo-EM","volume":"605","author":"Zhang","year":"2022","journal-title":"Nature"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PCBI.1011438","article-title":"Pathfinder: protein folding pathway prediction based on conformational sampling","volume":"19","author":"Huang","year":"2023","journal-title":"PloS Comput Biol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1002\/JCC.20011","article-title":"SPICKER: a clustering approach to identify near-native protein folds","volume":"25","author":"Zhang","year":"2004","journal-title":"J Comput Chem"},{"key":"B130","doi-asserted-by":"publisher","first-page":"4519","DOI":"10.1038\/s41467-024-48446-3","article-title":"A protein sequence-based deep transfer learning framework for identifying human proteome-wide deubiquitinase-substrate interactions","volume":"15","author":"Liu","year":"2024","journal-title":"Nat Commun"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1021\/ACS.JPCLETT.3C01592","article-title":"Four-dimensional-spacetime atomistic artificial intelligence models","volume":"14","author":"Ge","year":"2023","journal-title":"J Phys Chem Lett"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-08127-z","article-title":"Ab initio characterization of protein molecular dynamics with AI2BMD","volume":"635","author":"Wang","year":"2024","journal-title":"Nature"},{"key":"B133","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1128\/MMBR.05012-11","article-title":"Emerging role of ubiquitination in antiviral RIG-I signaling","volume":"76","author":"Maelfait","year":"2012","journal-title":"Microbiol Mol Biol Rev"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1002\/EJI.201746959","article-title":"Post-translational regulation of antiviral innate signaling","volume":"47","author":"Zhou","year":"2017","journal-title":"Eur J Immunol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1074\/JBC.RA118.005449","article-title":"Linear ubiquitination of cFLIP induced by LUBAC contributes to TNF\u03b1-induced apoptosis","volume":"293","author":"Tang","year":"2018","journal-title":"J Biol Chem"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1016\/J.CELREP.2024.114960","article-title":"TRIM65 regulates innate immune signaling by enhancing K6-linked ubiquitination of IRF3 and its chromatin recruitment","volume":"43","author":"Fonseca","year":"2024","journal-title":"Cell Rep"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.3389\/FCELL.2019.00392","article-title":"The role of atypical ubiquitin chains in the regulation of the antiviral innate immune response","volume":"7","author":"van Huizen","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00321-18","article-title":"TRIM21 promotes innate immune response to RNA viral infection through Lys27-linked polyubiquitination of MAVS","volume":"92","author":"Xue","year":"2018","journal-title":"J Virol"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.3389\/FMICB.2026.1768721","article-title":"The roles of post-translational modifications in the pathogenesis of RNA viruses: allies or adversaries","volume":"17","author":"Shao","year":"2026","journal-title":"Front Microbiol"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00855-24","article-title":"SARS-CoV-2 papain-like protease inhibits ISGylation of the viral nucleocapsid protein to evade host anti-viral immunity","volume":"98","author":"Rhamadianti","year":"2024","journal-title":"J Virol"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1002\/ADVS.202104126","article-title":"SUMOylation in viral replication and antiviral defense","volume":"9","author":"Fan","year":"2022","journal-title":"Adv Sci"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PPAT.1010446","article-title":"PIAS1-mediated SUMOylation of influenza A virus PB2 restricts viral replication and virulence","volume":"18","author":"Wang","year":"2022","journal-title":"PloS Pathog"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.3389\/FCELL.2022.890121","article-title":"Association between neddylation and immune response","volume":"10","author":"Zhu","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1002\/PROT.22555","article-title":"Identification, analysis, and prediction of protein ubiquitination sites","volume":"78","author":"Radivojac","year":"2010","journal-title":"Proteins: Structure Funct Bioinf"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1093\/NAR\/GKAB962","article-title":"UbiBrowser 2.0: a comprehensive resource for proteome-wide known and predicted ubiquitin ligase\/deubiquitinase\u2013substrate interactions in eukaryotic species","volume":"50","author":"Wang","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1016\/J.JMB.2015.09.014","article-title":"The HADDOCK2.2 web server: user-friendly integrative modeling of biomolecular complexes","volume":"428","author":"Van Zundert","year":"2016","journal-title":"J Mol Biol"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1002\/PRO.4379","article-title":"Benchmarking AlphaFold for protein complex modeling reveals accuracy determinants","volume":"31","author":"Yin","year":"2022","journal-title":"Protein Sci"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1126\/SCIENCE.ADT1630","article-title":"Predicting protein-protein interactions in the human proteome","volume":"390","author":"Zhang","year":"2025","journal-title":"Sci (1979)"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1038\/S41587-019-0224-X","article-title":"Deep learning enables rapid identification of potent DDR1 kinase inhibitors","volume":"37","author":"Zhavoronkov","year":"2019","journal-title":"Nat Biotechnol"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1093\/BIOADV\/VBAF200","article-title":"Multimodal deep learning for predicting protein ubiquitination sites","volume":"5","author":"Pakhrin","year":"2024","journal-title":"Bioinf Adv"},{"key":"B151","doi-asserted-by":"publisher","first-page":"4546","DOI":"10.1038\/s41467-025-59870-4","article-title":"A novel, covalent broad-spectrum inhibitor targeting human coronavirus Mpro","volume":"16","author":"Sun","year":"2025","journal-title":"Nat Commun"},{"key":"B152","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1021\/ACS.JCIM.2C01191","article-title":"Chemistry42: An AI-driven platform for molecular design and optimization","volume":"63","author":"Ivanenkov","year":"2023","journal-title":"J Chem Inf Model"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1021\/ACS.JMEDCHEM.1C02013","article-title":"Discovery of pentacyclic triterpenoid PROTACs as a class of effective hemagglutinin protein degraders","volume":"65","author":"Li","year":"2022","journal-title":"J Med Chem"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1016\/J.DRUDIS.2024.104205","article-title":"Advances in molecular glues: exploring chemical space and design principles for targeted protein degradation","volume":"29","author":"Hemant Kumar","year":"2024","journal-title":"Drug Discov Today"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1021\/ACSOMEGA.4C08049","article-title":"Molecular glue-design-evaluator (MOLDE): An advanced method for in-silico molecular glue design","volume":"10","author":"Ben Geoffrey","year":"2025","journal-title":"ACS Omega"},{"key":"B156","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1039\/D1DD00024A","article-title":"Deep generative models for peptide design","volume":"1","author":"Wan","year":"2022","journal-title":"Digital Discov"},{"key":"B157","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/S42979-023-02203-3","article-title":"PandoraGAN: Generating antiviral peptides using generative adversarial network","volume":"4","author":"Surana","year":"2023","journal-title":"SN Comput Sci"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1001\/JAMA.2020.6019","article-title":"Pharmacologic treatments for coronavirus disease 2019 (COVID-19): A review","volume":"323","author":"Sanders","year":"2020","journal-title":"JAMA"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1016\/S2589-7500(20)30192-8","article-title":"Artificial intelligence in COVID-19 drug repurposing","volume":"2","author":"Zhou","year":"2020","journal-title":"Lancet Digit Health"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1869543\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T04:25:57Z","timestamp":1781497557000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1869543\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":159,"alternative-id":["10.3389\/fimmu.2026.1869543"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1869543","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"article-number":"1869543"}}